Editorial

The Long Journey of Outpatient Parenteral Antibiotic Therapy in Infective Endocarditis: From Idea to Clinical Guidelines

Authors: Gabriel-Adrian Popescu MD, PhD

Abstract

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

References1.Antoniskis A, Anderson BC, Van Volkinburg EJ, et al. Feasibility of outpatient self-administration of parenteral antibiotics. West J Med 1978;128:203–206.AntoniskisA]]AndersonBC]]Van VolkinburgEJ&etal;Feasibility of outpatient self-administration of parenteral antibiotics.West J Med1978128203-2062.Larioza J, Heung L, Girard A, et al. Management of infective endocarditis in outpatients: clinical experience with outpatient parenteral antibiotic therapy. South Med J 2009;102:575–579.LariozaJ]]HeungL]]GirardA&etal;Management of infective endocarditis in outpatients: clinical experience with outpatient parenteral antibiotic therapy.South Med J2009102575-5793.Baddour LM, Wilson WR, Bayer AS, et al; Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease; Council on Cardiovascular Disease in the Young; Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia; American Heart Association; Infectious Diseases Society of America. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation 2005;111:e394–e434.BaddourLM]]WilsonWR]]BayerAS&etal;Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease; Council on Cardiovascular Disease in the Young; Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia; American Heart Association; Infectious Diseases Society of AmericaInfective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America.Circulation2005111e394-e4344.Horstkotte D, Follath F, Gutschik E, et al; Task Force Members on Infective Endocarditis of the European Society of Cardiology; ESC Committee for Practice Guidelines (CPG); Document Reviewers. Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary; the task force on infective endocarditis of the European society of cardiology. Eur Heart J 2004;25:267–276.HorstkotteD]]FollathF]]GutschikE&etal;Task Force Members on Infective Endocarditis of the European Society of Cardiology; ESC Committee for Practice Guidelines (CPG); Document ReviewersGuidelines on prevention, diagnosis and treatment of infective endocarditis executive summary; the task force on infective endocarditis of the European society of cardiology.Eur Heart J200425267-2765.Stamboulian D. Outpatient treatment of endocarditis in a clinic-based program in Argentina. Review. Eur J Clin Microbiol Infect Dis 1995;14:648–654.StamboulianDOutpatient treatment of endocarditis in a clinic-based program in Argentina. Review.Eur J Clin Microbiol Infect Dis199514648-6546.Pfaller MA, Jones RN, Marshall SA, et al. Nosocomial streptococcal blood stream infections in the SCOPE Program: species occurrence and antimicrobial resistance. The SCOPE Hospital Study Group. Diagn Microbiol Infect Dis 1997;29:259–263.PfallerMA]]JonesRN]]MarshallSA&etal;Nosocomial streptococcal blood stream infections in the SCOPE Program: species occurrence and antimicrobial resistance. The SCOPE Hospital Study Group.Diagn Microbiol Infect Dis199729259-2637.Mock CN, Jurkovich GJ, Dries DJ, et al. Clinical significance of antibiotic endotoxin-releasing properties in trauma patients. Arch Surg 1995;130:1234–1240; discussion 1240–1241.8.Francioli P, Etienne J, Hoigné R, et al. Treatment of streptococcal endocarditis with a sigle daily dose of ceftriaxone sodium for 4 weeks. Efficacy and outpatient treatment feasibility. JAMA 1992;267:264–267.FrancioliP]]EtienneJ]]HoignéR&etal;Treatment of streptococcal endocarditis with a sigle daily dose of ceftriaxone sodium for 4 weeks. Efficacy and outpatient treatment feasibility.JAMA1992267264-2679.Francioli PB. Ceftriaxone and outpatient treatment of infective endocarditis. Infect Dis Clin North Am 1993;7:97–115.FrancioliPBCeftriaxone and outpatient treatment of infective endocarditis.Infect Dis Clin North Am1993797-11510.Graninger W, Presterl E, Wenisch C, et al. Management of serious staphylococcal infections in the outpatient setting. Drugs 1997;54(suppl 6):21–28.GraningerW]]PresterlE]]WenischC&etal;Management of serious staphylococcal infections in the outpatient setting.Drugs19975421-28